-
Abstract Number: 1604
The Systemic Lupus Erythematosus Cardiovascular Risk Equation
-
Abstract Number: 1605
Homocysteinemia Predicts Renal Insufficiency in Systemic Lupus Erythematosus
-
Abstract Number: 1606
Association of African- American Ethnicity and Smoking Status and Total and Individual Damage Index in Systemic Lupus Erythematosus
-
Abstract Number: 1607
Risk Factors for Avascular Necrosis in SLE: A Multivariate Model
-
Abstract Number: 1608
Effect of the Metabolic Syndrome on Renal Function Decline in Four Rheumatic Diseases: An 8-year Longitudinal Analysis
-
Abstract Number: 1609
Organ Damage Free Survival in Southern Chinese Patients with Active Lupus Nephritis
-
Abstract Number: 1610
Prediction of Organ Damage Accrual in Systemic Lupus Erythematosus Using a Frailty Index
-
Abstract Number: 1611
Systemic Lupus Erythematosus Registries: Are the Measures Captured in the Real World Similar to Those in Clinical Trials?
-
Abstract Number: 1612
Disease Activity and Cognitive Function in Systemic Lupus Erythematosus
-
Abstract Number: 1613
LDL-cholesterol as a Risk Factor of Progression to ESRD in Patients with Lupus Nephritis
-
Abstract Number: 1614
Factors Associated with Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus: A Single Center Experience
-
Abstract Number: 1615
The Effects of Anti-glutamate Receptor Subunit Antiantibodies on Systemic Lupus Erythematosus Without Neuropsychiatric Involvement
-
Abstract Number: 1616
Do All Antiphospholipid Antibodies Confer the Same Risk for Major Organ Involvement in Systemic Lupus Erythematosus Patients?
-
Abstract Number: 1617
Platelet Bound Complement Split Product (PC4d) May Be a Marker of Platelet Activation and Cardiovascular Events in Systemic Lupus Erythematosus
-
Abstract Number: 1618
Factors Associated with Damage Accrual in SLE Patients with No Clinical or Serological Disease Activity
- « Previous Page
- 1
- …
- 108
- 109
- 110
- 111
- 112
- …
- 198
- Next Page »